Invention Grant
- Patent Title: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
-
Application No.: US16888883Application Date: 2020-06-01
-
Publication No.: US11214574B2Publication Date: 2022-01-04
- Inventor: Juan Luengo , Hong Lin , Michael Hawkins , Rupa Shetty , Philip Pitis , Gisela Saborit Villarroya
- Applicant: Prelude Therapeutics, Incorporated
- Applicant Address: US DE Wilmington
- Assignee: Prelude Therapeutics, Incorporated
- Current Assignee: Prelude Therapeutics, Incorporated
- Current Assignee Address: US DE Wilmington
- Agency: BakerHostetler
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00 ; A61P35/00
Abstract:
The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
Public/Granted literature
- US20200291037A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) Public/Granted day:2020-09-17
Information query
